1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. By-health Co., Ltd.
  6. Summary
    300146   CNE100000Y84

BY-HEALTH CO., LTD.

(300146)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-08-04
18.26 CNY   +2.18%
08/05By-health Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
04/28By-health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/06By-Health Co., Ltd. Implements Cash Dividend for 2021, Payable on 13 April 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
08/01/2022 08/02/2022 08/03/2022 08/04/2022 08/05/2022 Date
18.5 17.61 17.78 17.87 18.26 Last
7521090 16226710 7697935 6801078 7117120 Volume
+0.11% -4.81% +0.97% +0.51% +2.18% Change
Estimated financial data (e)
Sales 2022 8 594 M 1 271 M 1 271 M
Net income 2022 1 935 M 286 M 286 M
Net cash position 2022 3 034 M 449 M 449 M
P/E ratio 2022 15,6x
Yield 2022 4,15%
Sales 2023 10 294 M 1 522 M 1 522 M
Net income 2023 2 382 M 352 M 352 M
Net cash position 2023 3 245 M 480 M 480 M
P/E ratio 2023 12,9x
Yield 2023 4,80%
Capitalization 31 048 M 4 592 M 4 592 M
EV / Sales 2022 3,26x
EV / Sales 2023 2,70x
Nbr of Employees 3 299
Free-Float 25,8%
More Financials
Company
By-health Co.,Ltd is a China-based company principally engaged in the research, development, production and distribution of nutrition supplements. The Company's main products include protein powders, vitamin C tablets, vitamin B tablets, natural vitamin E capsules, vitamin A and D soft capsules, calcium and vitamin D soft capsules, bovine colostrum calcium tablets, bone collagen calcium tablets, spirulina tablets,... 
Sector
Food Processing
Calendar
08/06Earnings Release
More about the company
Ratings of By-health Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D
More Ratings
All news about BY-HEALTH CO., LTD.
08/05By-health Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
04/28By-health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/06By-Health Co., Ltd. Implements Cash Dividend for 2021, Payable on 13 April 2022
CI
03/28By-Health Co., Ltd. Approves Cash Dividend for 2021
CI
03/07BY-Health Sticks to 2021 Dividend on Double-Digit Jump in Earnings
MT
03/07By-health Co., Ltd. Proposes Cash Dividend for 2021
CI
03/04By-health Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2021By-health Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 20..
CI
2021By-Health Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021By-health Co., Ltd. announced that it has received CNY 3.125351076 billion in funding f..
CI
2021By-Health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
2021By-Health Co., Ltd. Announces 2020 Final Profit Distribution Plan to Be Implemented (A ..
CI
2021By-Health Co., Ltd. Proposes Final Distribution Plan for 2020
CI
2021By-Health Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
2020PENTAVITE : an 80-year-old Brand of Professional Vitamin for Children in Australia, Kicks ..
BU
More news
News in other languages on BY-HEALTH CO., LTD.
08/05By-health Co., Ltd. annonce ses résultats pour le semestre se terminant le 30 juin 2022
04/28By-health Co., Ltd. annonce ses résultats pour le premier trimestre se terminant le 31 ..
04/06By-Health Co., Ltd. met en place un dividende en espèces pour 2021, payable le 13 avril..
03/28By-Health Co., Ltd. approuve le dividende en espèces pour 2021
03/07BY-Health maintient son dividende pour 2021 grâce à une hausse à deux chiffres de ses b..
More news
Chart BY-HEALTH CO., LTD.
Duration : Period :
By-health Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BY-HEALTH CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 18,26 CNY
Average target price 31,82 CNY
Spread / Average Target 74,3%
EPS Revisions
Managers and Directors
Zhi Cheng Lin General Manager & Director
Zhuo Yi Wu Chief Financial & Accounting Officer
Yun Chao Liang Chairman
Wen Wang Chief Financial Officer
Xi Wang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BY-HEALTH CO., LTD.-32.27%4 592
ZHEJIANG NHU COMPANY LTD.-21.88%9 209
BALCHEM CORPORATION-24.37%4 095
BELLRING BRANDS, INC.-12.51%3 401
THE SIMPLY GOOD FOODS COMPANY-18.84%3 387
HERBALIFE NUTRITION LTD.-32.13%2 719